Amarantus Bioscience Holdings, Inc. Contracts & Agreements

SECURITIESPURCHASE AGREEMENT (Filed With SEC on April 17, 2017)

AMENDMENTNO. 1 TO PLEDGE AGREEMENT (Filed With SEC on April 17, 2017)

SECONDAMENDMENT TO INTERCREDITOR AND SUBORDINATION GREEMENT (Filed With SEC on April 17, 2017)

SENIORSECURED CONVERTIBLE NOTE (Filed With SEC on April 17, 2017)

(Signatureson following page) (Filed With SEC on March 28, 2017)

SECURITIESPURCHASE AGREEMENT (Filed With SEC on March 28, 2017)

SECURITIESPURCHASE AGREEMENT (Filed With SEC on November 8, 2016)

PLEDGE AGREEMENT (Filed With SEC on November 8, 2016)

FirstAmendment to Intercreditor and Subordination Agreement (Filed With SEC on November 8, 2016)

AmarantusBioscience Holdings, Inc. SeniorSecured Convertible Note (Filed With SEC on November 8, 2016)

CONVERTIBLE PROMISSORY NOTE (Filed With SEC on November 8, 2016)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on April 21, 2016)

10%original issue discount SENIOR SECURED CONVERTIBLE PROMISSORY NOTE DUE April 14, 2017 (Filed With SEC on April 21, 2016)

COMMONSTOCK PURCHASE WARRANT AmarantusBioscience Holdings, Inc. (Filed With SEC on April 21, 2016)

SECURITY AGREEMENT (Filed With SEC on April 21, 2016)

INTELLECTUAL PROPERTY SECURITY AGREEMENT (Filed With SEC on April 21, 2016)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on April 21, 2016)

SUBSIDIARY GUARANTEE (Filed With SEC on April 21, 2016)

8%CONVERTIBLE NOTE DUEFebruary 28, 2017 (Filed With SEC on March 7, 2016)

SECURITIESPURCHASE AGREEMENT (Filed With SEC on February 24, 2016)

COMMON STOCK PURCHASE WARRANT AMARANTUSBIOSCIENCE HOLDINGS, INC. (Filed With SEC on February 24, 2016)

LEAK-OUTAGREEMENT (Filed With SEC on February 24, 2016)

PLACEMENT AGENCY AGREEMENT (Filed With SEC on February 24, 2016)

SECURITIESPURCHASE AGREEMENT (Filed With SEC on January 28, 2016)

LEAK-OUTAGREEMENT (Filed With SEC on January 28, 2016)

STOCKREPURCHASE AGREEMENT (Filed With SEC on January 28, 2016)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on October 1, 2015)

COMMON STOCK PURCHASE WARRANT AmarantusBioscience Holdings, Inc. (Filed With SEC on October 1, 2015)

SECURITIES PURCHASE AGREEMENT dated as of September 30, 2015 by and among DELAFIELD INVESTMENTS LIMITED (LENDER) and AMARANTUS BIOSCIENCE HOLDINGS, INC. (BORROWER) (Filed With SEC on October 1, 2015)

12%SENIOR SECURED CONVERTIBLE PROMISSORY NOTE DUESeptember 29, 2016 (Filed With SEC on October 1, 2015)

SECURITYAGREEMENT (Filed With SEC on October 1, 2015)

PATENT AND TRADEMARK SECURITY AGREEMENT (Filed With SEC on October 1, 2015)

EXCHANGE AGREEMENT (Filed With SEC on October 1, 2015)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on October 1, 2015)

AMARANTUS BIOSCIENCE HOLDINGS, INC. LetterAgreement dated September 30, 2015 (Filed With SEC on October 1, 2015)

REPURCHASE AGREEMENT (Filed With SEC on October 1, 2015)

AMENDED AND RESTATED STOCK PURCHASEAGREEMENT (Filed With SEC on July 15, 2015)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on July 15, 2015)

12%PROMISSORY NOTE DUEJuly 9, 2016 (Filed With SEC on July 15, 2015)

SECURITY AGREEMENT (Filed With SEC on July 15, 2015)

12%PROMISSORY NOTE DUEAPRIL 2, 2016 (Filed With SEC on July 8, 2015)

STOCKPURCHASE AGREEMENT (Filed With SEC on April 28, 2015)

AMENDMENT TO ASSETPURCHASE AGREEMENT (Filed With SEC on April 6, 2015)

AMENDMENT NO. 2 TO OPTION AGREEMENT (Filed With SEC on April 6, 2015)

AMARANTUSBIOSCIENCE HOLDINGS, INC. AMENDED AND RESTATED CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS OF SERIES E12% CONVERTIBLE PREFERRED STOCK (PURSUANTTO... (Filed With SEC on April 6, 2015)

AMENDMENT NO. 3 TO OPTION AGREEMENT (Filed With SEC on March 31, 2015)

SETTLEMENTAGREEMENT (Filed With SEC on February 25, 2015)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on February 25, 2015)

12%PROMISSORY NOTE DUEDECEMBER 23, 2015 (Filed With SEC on February 25, 2015)

SECURITYAGREEMENT (Filed With SEC on February 25, 2015)

AGREEMENT AND PLAN OF MERGER by and among AmarantusBioScience Holdings, Inc. NeuroAcquisition Corporation, DioGenixInc., and Nerveda,LLC, as the SecurityholderRepresentative... (Filed With SEC on January 13, 2015)

First Amendment to Option Agreement (Filed With SEC on January 12, 2015)

OPTION AGREEMENT (Filed With SEC on November 17, 2014)

ASSET PURCHASE AGREEMENT (Filed With SEC on November 17, 2014)

SECURITIESPURCHASE AGREEMENT (Filed With SEC on November 14, 2014)

SPONSORED RESEARCH AGREEMENT (Filed With SEC on August 15, 2014)

OPTION AGREEMENT (Filed With SEC on August 15, 2014)

LICENSE AGREEMENT Between PGI Drug Discovery LLC. and Amarantus BioScience Holdings Inc. (Filed With SEC on August 15, 2014)

ASSET PURCHASE AGREEMENT (Filed With SEC on May 20, 2014)

OPTION AGREEMENT (Filed With SEC on April 21, 2014)

EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on April 21, 2014)

Amarantus Bioscience Holdings, Inc. DemandPromissory Note (Filed With SEC on April 21, 2014)

OPTION AGREEMENT (Filed With SEC on April 21, 2014)

PURCHASE AGREEMENT (Filed With SEC on March 13, 2014)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on March 13, 2014)

COMMON STOCK PURCHASE WARRANT AmarantusBioScience Holdings, Inc. (Filed With SEC on March 13, 2014)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on December 2, 2013)

SUBSIDIARY GUARANTEE (Filed With SEC on December 2, 2013)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on December 2, 2013)

8%ORIGINAL ISSUE DISCOUNT SENIOR CONVERTIBLE DEBENTURE DUEOctober 2, 2014 (Filed With SEC on December 2, 2013)

AMENDMENT NO.1 TO REGISTRATION RIGHTS AGREEMENT (Filed With SEC on December 2, 2013)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on September 9, 2013)

8%ORIGINAL ISSUE DISCOUNT SENIOR CONVERTIBLE DEBENTURE DUESEPTEMBER ___, 2014 (Filed With SEC on September 9, 2013)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on September 9, 2013)

COMMON STOCK PURCHASE WARRANT AmarantusBioScience Holdings, Inc. (Filed With SEC on September 9, 2013)

Securities Purchase Agreement dated as of August 19, 2013 (Filed With SEC on August 19, 2013)

Amendment No 1 to Convertible Promissory Note issued to Dominion Capital, LLC (Filed With SEC on April 17, 2013)

Amendment No. 2 to Convertible Promissory Note issued to Dominion Capital, LLC (Filed With SEC on April 17, 2013)

Amended and Restated Convertible Promissory note - $375,000 (Filed With SEC on April 17, 2013)

Amended and Restated Convertible Promissory note - $187,500 (Filed With SEC on April 17, 2013)

AGREEMENT ANDPLAN OF MERGER (Filed With SEC on April 1, 2013)

Articles of Merger (Pursuant to NRS Chapter 92A) (Filed With SEC on April 1, 2013)

AGREEMENT OF TERMINATION AND RELEASE (Filed With SEC on April 1, 2013)

Amarantus BioScience Acquires Neurodegenerative Diagnostic Intellectual Property Portfoliofrom Power3 Medical Products (Filed With SEC on December 26, 2012)

EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on December 21, 2012)

Convertible Promissory Note issued to Dominion Capital, LLC (Filed With SEC on November 19, 2012)

Stipulation and Order with Ironridge Global IV, Ltd (Filed With SEC on November 19, 2012)

Convertible Promissory Note (Filed With SEC on September 21, 2012)

Exclusive License Agreement (Filed With SEC on January 30, 2012)

Investment Agreement (Filed With SEC on October 17, 2011)

Registration Rights Agreement (Filed With SEC on October 17, 2011)

Certificate of Amendment (Filed With SEC on October 14, 2011)

Note Purchase Agreement (Filed With SEC on October 11, 2011)

Promissory Note (Filed With SEC on October 11, 2011)

Letter Agreement regarding Pledged Shares (Filed With SEC on October 11, 2011)

Assignment and Assumption Agreement (Filed With SEC on June 15, 2011)

Consent to Assignment (Filed With SEC on June 15, 2011)

Lease Agreement, as amended (Filed With SEC on June 15, 2011)

Agreement and Plan of Merger (Filed With SEC on June 3, 2011)

Senior Secured Convertible Promissory Note Agreement (Filed With SEC on June 3, 2011)

Second Amendment to Senior Secured Convertible Promissory Note Agreement (Filed With SEC on June 3, 2011)

Convertible Promissory Note Agreement as Amended March 23, 2011 (Filed With SEC on June 3, 2011)

Note and Warrant Purchase Agreement Molecular Medicine Research Institute (Filed With SEC on June 3, 2011)

Sponsored Research Agreement (Filed With SEC on June 3, 2011)

Note and Warrant Purchase Agreement The Parkinsons Institute (Filed With SEC on June 3, 2011)

Promissory Note Neurotrophics, Inc (Filed With SEC on June 3, 2011)

Intellectual Property Assignment (Filed With SEC on June 3, 2011)

Data Transfer Agreement (Filed With SEC on June 3, 2011)

Consulting Agreement with Keelin Reeds Partners (Filed With SEC on June 3, 2011)

Executive Services Agreement, as Amended (Filed With SEC on June 3, 2011)

MJFF Research Grant Terms and Conditions (Filed With SEC on June 3, 2011)

2008 Stock Plan (Filed With SEC on June 3, 2011)

Letter of Agreement with Argot Partners, LLC (Filed With SEC on June 3, 2011)

Letter Agreement regarding Intellectual Properties Licensing and Collaboration Arrangements (Filed With SEC on June 3, 2011)

Agreement and Plan of Merger (Filed With SEC on May 31, 2011)

Senior Secured Convertible Promissory Note Agreement (Filed With SEC on May 31, 2011)

Second Amendment to Senior Secured Convertible Promissory Note Agreement (Filed With SEC on May 31, 2011)

Convertible Promissory Note Agreement as Amended March 23, 2011 (Filed With SEC on May 31, 2011)

Note and Warrant Purchase Agreement Molecular Medicine Research Institute (Filed With SEC on May 31, 2011)

Sponsored Research Agreement (Filed With SEC on May 31, 2011)

Note and Warrant Purchase Agreement The Parkinsons Institute (Filed With SEC on May 31, 2011)

Promissory Note Neurotrophics, Inc (Filed With SEC on May 31, 2011)

Intellectual Property Assignment (Filed With SEC on May 31, 2011)

Data Transfer Agreement (Filed With SEC on May 31, 2011)

Consulting Agreement with Keelin Reeds Partners (Filed With SEC on May 31, 2011)

Executive Services Agreement, as Amended (Filed With SEC on May 31, 2011)

MJFF Research Grant Terms and Conditions (Filed With SEC on May 31, 2011)

2008 Stock Plan (Filed With SEC on May 31, 2011)

Letter of Agreement with Argot Partners, LLC (Filed With SEC on May 31, 2011)

Agreement and Plan of Merger (Filed With SEC on May 27, 2011)

Senior Secured Convertible Promissory Note Agreement (Filed With SEC on May 27, 2011)

Second Amendment to Senior Secured Convertible Promissory Note Agreement (Filed With SEC on May 27, 2011)

Convertible Promissory Note Agreement as Amended March 23, 2011 (Filed With SEC on May 27, 2011)

Note and Warrant Purchase Agreement Molecular Medicine Research Institute (Filed With SEC on May 27, 2011)

Sponsored Research Agreement (Filed With SEC on May 27, 2011)

Note and Warrant Purchase Agreement The Parkinsons Institute (Filed With SEC on May 27, 2011)

Promissory Note Neurotrophics, Inc (Filed With SEC on May 27, 2011)

Intellectual Property Assignment (Filed With SEC on May 27, 2011)

Data Transfer Agreement (Filed With SEC on May 27, 2011)

Consulting Agreement with Keelin Reeds Partners (Filed With SEC on May 27, 2011)

Executive Services Agreement, as Amended (Filed With SEC on May 27, 2011)

MJFF Research Grant Terms and Conditions (Filed With SEC on May 27, 2011)

2008 Stock Plan (Filed With SEC on May 27, 2011)

Letter of Agreement with Argot Partners, LLC (Filed With SEC on May 27, 2011)

Category

Industry

Companies

Contracts

Amarantus Bioscience Holdings, Inc. Contracts & Agreements